EPIX Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1988-01-01
- Employees
- 91
- Market Cap
- -
- Website
- http://www.epixpharma.com
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 236
- Registration Number
- NCT00693004
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸Meridien Research, St. Petersburg, Florida, United States
🇺🇸Torrance Clinical Research, Torrance, California, United States
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00677872
- Locations
- 🇺🇸
Massachusetts General Hospital Pulmonary and Critical Care Unit, Boston, Massachusetts, United States
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT00672945
- Locations
- 🇺🇸
Bradenton Research Center, Bradenton, Florida, United States
🇺🇸Berma Research Group, Plantation, Florida, United States
🇺🇸Maine Neurology, Scarborough, Maine, United States
A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- Drug: Placebo for PRX-00023
- First Posted Date
- 2007-03-16
- Last Posted Date
- 2007-11-14
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 330
- Registration Number
- NCT00448292
- Locations
- 🇺🇸
AVI Clinical Research, Torrance, California, United States
🇺🇸Vince and Associates Clinical Research, Overland Park, Kansas, United States
🇺🇸University of Texas - Southwestern Medical Center, Dallas, Texas, United States
Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2008-01-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00384423
- Locations
- 🇺🇸
Southwest CLinical Research, Rancho Mirage, California, United States
🇺🇸Comprehensive NeuroScience, Inc, St. Petersburg, Florida, United States
🇺🇸Atlanta Center for Medical Research, Atlanta, Georgia, United States
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- Conditions
- Pulmonary HypertensionChronic Obstructive Pulmonary Disease
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT00345774
- Locations
- 🇺🇸
Pulmonary Consultants of North Idaho, Coeur d'Alene, Idaho, United States
🇺🇸Central Medical Group, PA, Tamarac, Florida, United States
🇺🇸Buffalo Cardiology and Pulmonary Associates, P.C., Williamsville, New York, United States
A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
- Conditions
- Anxiety Disorders
- First Posted Date
- 2005-11-03
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 310
- Registration Number
- NCT00248183
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Vista Medical Research, Mesa, Arizona, United States
🇺🇸Gulf Coast Clinical Research Center, Fort Myers, Florida, United States